This profile has not been claimed and data may not be accurate.
70th percentile
89th percentile
Blackstone Life Sciences Senior MD and co-founder of Praxis Precision Medicines
Credibility
Firm Standing · 91th percentile
- Active GP / fund manager role at Blackstone Life Sciences, deploying capital into life science companies.
- Previously a Venture Partner at Clarus Ventures (Dec 2015 – Nov 2018), a recognized life sciences VC firm.
- Previously an Associate Partner at Third Rock Ventures (Jun 2008 – Oct 2014), a leading healthcare venture firm.
Relationship Matrix
Most Like You
Most Complimentary
Founder score
- 95%Probability of being accurate (95%)blackstone.com ranks #11,578 on the Majestic Million (global domain prominence).
- 95%Probability of being accurate (95%)Past founder and CEO of Praxis Precision Medicines, which he co-founded in November 2016.
- 95%Probability of being accurate (95%)Praxis Precision Medicines raised at least $18.8M per SEC Form D filings.
- 95%Probability of being accurate (95%)Praxis Precision Medicines went public via IPO, confirmed by SEC S-1 and ongoing 10-K/10-Q filings.
- 80%Probability of being accurate (80%)Praxis Precision Medicines was co-founded with at least one other co-founder.
- 40%Probability of being accurate (40%)Stack Overflow account identified for Kiran Reddy with 2,934 reputation.
Investor score
- 95%Probability of being accurate (95%)Partner / Principal at Blackstone Life Sciences, a major recognized alternative asset and life sciences investment firm.
- 90%Probability of being accurate (90%)Previously an Associate Partner at Third Rock Ventures (Jun 2008 – Oct 2014), a leading healthcare venture firm.
- 88%Probability of being accurate (88%)Active GP / fund manager role at Blackstone Life Sciences, deploying capital into life science companies.
- 85%Probability of being accurate (85%)Previously a Venture Partner at Clarus Ventures (Dec 2015 – Nov 2018), a recognized life sciences VC firm.
- 45%Probability of being accurate (45%)Has made at least 1 notable investment in African startups including Ryonic Robotics, per StartupList Africa.
What you likely need
You'd get the most out of Festival events that put you in rooms with early-stage neuroscience and biopharma founders who need a mentor with real operator credibility, not just a check. High-signal positioning dinners with other life sciences investors and conference speakers would help you build the public thought leadership profile that your Blackstone role alone won't create. Structured roundtables around emerging-markets biotech and angel syndicate mechanics would let you turn two nascent interests into trackable, differentiated theses.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- positioningA life sciences investor dinner with other neuroscience-focused VCs and biopharma operators to workshop 2-3 publishable theses on CNS drug development trends worth putting your name on publicly
- positioningA founder-to-IPO storytelling roundtable with other biotech founders who've taken companies public, to help you shape and pressure-test the Praxis Precision Medicines narrative for LP and co-investor audiences
- introsA YC life sciences alumni dinner spanning recent S21–S24 batches for warm intros to early-stage neuroscience and biopharma founders whose seed-stage deals could feed Blackstone's later-stage pipeline
- positioningA speaker prep roundtable with founders and investors who've presented at BIO International and SXSW Health to sharpen your talk angle and get warm intros to the program committees
- tacticalA tactical happy hour with AngelList power users and life sciences angels who've formalized personal syndicates, to map the exact steps for standing up a trackable public portfolio alongside your Blackstone role
- introsAn intimate office-hours session pairing you with 4-5 pre-seed neuroscience founders from recent YC and Petri batches who need a mentor with both Praxis operator experience and institutional VC pattern recognition
- fundraisingA dinner with Africa-focused emerging-markets investors and early-stage health-tech founders from Nairobi and Lagos to stress-test a structured African biotech and diagnostics investment thesis you could own publicly